You can help expand this article with text translated from the corresponding article in Russian. (September 2023) Click [show] for important translation instructions.
|
| Names | |
|---|---|
| IUPAC name
13-Oxo-12,13-dihydrobenzo[2,3]indolizino[8,7-b]indol-5-ium | |
| Other names
LSM-4272 | |
| Identifiers | |
| |
3D model (JSmol) |
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
PubChem CID |
|
| |
| |
| Properties | |
| C18H11N2O+ | |
| Molar mass | 271.298 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Fascaplysin is a marine alkaloid based on 12H-pyrido[1–2-a:3,4-b′]diindole ring system. It was first isolated as a red pigment from the marine sponge Fascaplysinopsis reticulata that was collected in the South Pacific near Fiji in 1988. Fascaplysin possesses a broad range of in vitro biological activities including analgesic, antimicrobial, antifungal, antiviral, antimalarial, anti-angiogenic, and antiproliferative activity against numerous cancer cell lines.
The first total synthesis of fascaplysin was performed in seven steps from indole in 1990. Fascaplysin and its derivatives can be synthesized from tryptamine, beta-carboline, indoleketones, and indigo.